These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2774968)

  • 1. Effect of netilmicin and amikacin on urinary phospholipids excretion in humans.
    Ibrahim S; Van der Auwera P; Meunier F; Tulkens PM
    Arch Toxicol Suppl; 1989; 13():413-6. PubMed ID: 2774968
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetic and toxicological evaluation of a once-daily regimen versus conventional schedules of netilmicin and amikacin.
    Tulkens PM
    J Antimicrob Chemother; 1991 May; 27 Suppl C():49-61. PubMed ID: 1856146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect and pharmacokinetics of netilmicin given as bolus intramuscular administration: an open comparative trial versus amikacin and fosfomycin in elderly patients affected by urinary tract infections.
    Caramalli S; Amprimo MC; Cavalli G; Mantelli M; Pollastrelli E; Raiteri F; Varese LA; Franchino L
    Int J Clin Pharmacol Res; 1991; 11(2):55-65. PubMed ID: 1879990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of netilmicin therapy in serious infections.
    Jahre JA; Fu KP; Neu HC
    Am J Med; 1979 Jan; 66(1):67-73. PubMed ID: 420253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of the ototoxicity of amikacin and netilmicin using provoked acoustic oto-emissions and high-frequency audiometry].
    Collet L; Veuillet E; Chanal JM; Desreux V; Mermet B; Disant F; Morgon A
    Pathol Biol (Paris); 1992 Dec; 40(10):990-2. PubMed ID: 1299814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Netilmicin treatment of complicated urinary tract infections.
    Madsen PO; Baumueller A; Frimodt-Møller N; Hoyme U; Lau C; Maigaard S; Nielsen OS; Welling PG
    Scand J Infect Dis Suppl; 1980; Suppl 23():128-31. PubMed ID: 6937956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Netilmicin. Laboratory and clinical studies.
    Wang F; Zhang YY; Zhang MF; Zhang JD; Gu JW; Zhang J; Zhou L; Wu PC; Liu YK; Dai ZY
    Chin Med J (Engl); 1988 Oct; 101(10):776-80. PubMed ID: 3150713
    [No Abstract]   [Full Text] [Related]  

  • 8. [In vitro activity of netilmicin compared to the activity of other antibiotics against strains of urinary enterobacteria].
    Vanni M; Deambrogio P
    Minerva Med; 1985 Sep; 76(36):1619-21. PubMed ID: 4047448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical study on netilmicin in the treatment of complicated urinary tract infection caused by Pseudomonas aeruginosa].
    Murahashi I; Honda M; Maeda S; Takasaki E
    Jpn J Antibiot; 1982 Aug; 35(8):1919-24. PubMed ID: 6818388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical evaluations of netilmicin in urinary tract infections].
    Saito I
    Jpn J Antibiot; 1982 Aug; 35(8):1925-33. PubMed ID: 7154243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the resistance mechanisms of gentamicin-resistant Gram-negative bacilli and their susceptibility to tobramycin, netilmicin and amikacin.
    Maes P
    J Antimicrob Chemother; 1985 Mar; 15(3):283-9. PubMed ID: 3997704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on good use of injectable aminoglycosides, gentamycin, tobramycin, netilmycin, amikacin. Pharmacological properties, indications, dosage, and mode of administration, treatment monitoring.
    Agence française de sécurité sanitaire des produits de santé
    Med Mal Infect; 2012 Jul; 42(7):301-8. PubMed ID: 22770656
    [No Abstract]   [Full Text] [Related]  

  • 13. Sensitivity of gentamicin-resistant gram-negative bacilli to tobramycin, netilmicin and amikacin as well as synergism with cephalosporins.
    Kedzia WB; Mirska I
    J Chemother; 1989 Jul; 1(4 Suppl):367-8. PubMed ID: 16312443
    [No Abstract]   [Full Text] [Related]  

  • 14. Amikacin and netilmicin resistance in Pseudomonas aeruginosa: incidence and transfer.
    Knothe H; Krcméry V
    Chemotherapy; 1979; 25(1):23-9. PubMed ID: 105839
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical experience of netilmicin on chronic urinary tract infections (author's transl)].
    Yamamoto Y; Satoh K; Unno R; Miyazaki R
    Jpn J Antibiot; 1982 Jan; 35(1):273-80. PubMed ID: 7069932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical applications of sisomicin and netilmicin. Previous and current state of microbiological results].
    Altucci P; Abbate GF; Alagia I; D'Aprea L; D'Aprea L; D'Aprea L; D'Aprea L; Sepe V
    G Ital Chemioter; 1979; 26(1-2):41-56. PubMed ID: 122080
    [No Abstract]   [Full Text] [Related]  

  • 17. Bacterial resistance after in vitro exposure to amikacin and netilmicin.
    van de Klundert JA; Vliegenthart JS; Mouton RP
    Eur J Clin Microbiol; 1986 Aug; 5(4):456-8. PubMed ID: 3093226
    [No Abstract]   [Full Text] [Related]  

  • 18. [In vitro antibacterial activity of piperacillin-tazobactam in combination with netilmicin or amikacin against Enterobacteriaceae resistant to amoxicillin].
    Duez JM; Siebor E; Pechinot A; Cordin X; Chamard-Neuwirth C; Kazmierczak A
    Pathol Biol (Paris); 1995 Mar; 43(3):208-14. PubMed ID: 7675548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of netilmicin, gentamicin, tobramycin and amikacin against glucose fermenting and nonfermenting bacteria.
    DiPersio JR; Krafczyk TL
    Chemotherapy; 1980; 26(5):323-33. PubMed ID: 7389428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro activity of netilmicin, amikacin, tobramycin and sisomicin against gentamicin highly-resistant enterobacteriaceae.
    Tselentis J; Legakis NJ; Nicolas KJ; Melissinos K; Papavassiliou J
    Chemotherapy; 1980; 26(6):409-17. PubMed ID: 7408554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.